Latest Innovation News

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Race Oncology has announced pivotal new clinical trials for its lead asset RC220, aiming to accelerate regulatory approval in Acute Myeloid Leukemia and tackle resistance in Non-Small Cell Lung Cancer.

Orcoda Limited announces a pivotal leadership transition with Patrick Bodegraven stepping in as Managing Director, while long-serving Geoff Jamieson shifts to a part-time CFO role to support continuity.

Elders Limited reported a robust FY25 with a 12% rise in underlying EBIT to $143.5 million, driven by strong livestock prices and real estate growth despite challenging seasonal conditions. The acquisition of Delta Agribusiness and ongoing systems modernization underpin the company’s diversified growth strategy.

Elders Limited reported a solid FY25 with a 12% rise in profit after tax to $50.3 million, completing the strategic acquisition of Delta Agribusiness and advancing key operational and sustainability initiatives.

Calix Limited has secured a pivotal $35 million joint development agreement with Rio Tinto to advance its Zesty Green Iron Demonstration Plant in Western Australia, backed by a substantial ARENA grant. This collaboration aims to pioneer low-emission steel production using innovative hydrogen and electric heating technology.

Radiopharm Theranostics has reached the halfway mark in enrolling patients for its Phase 2b trial of RAD101, a novel imaging agent targeting brain metastases. Early data suggest RAD101 may outperform MRI in distinguishing tumor recurrence from radiation damage.

Bioxyne Limited is expanding its footprint with a new UK GMP-certified medicinal cannabis manufacturing site, backed by £850,000 in funding from South of Scotland Enterprise. This move positions the company to tap into the UK’s growing medicinal cannabis market, the second largest in Europe.

Neometals’ Finnish subsidiary Novana Oy has been awarded a €48.7 million conditional grant from Business Finland to advance its €400 million Vanadium Recovery Project in Pori, aiming to produce up to 60% of Europe’s vanadium demand with a low-carbon footprint.

FleetPartners has acquired Remunerator, a seasoned salary packaging and novated lease provider, enhancing its product suite and market position in the leasing sector.

Solvar Limited reported solid FY25 results with profit growth, a significant dividend hike, and a positive outlook for FY26 driven by loan originations and commercial lending expansion.

Starpharma’s 2025 AGM highlighted breakthrough partnerships and clinical progress, positioning the biotech for growth. Key deals with Genentech and Radiopharm Theranostics underpin a promising pipeline and expanding revenue streams.